Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results

European Heart Journal

Volumn 36, Issue 2, 2015, Pages 112-119

  Atar, Dan ^a   Arheden, Hakan ^b   Berdeaux, Alain ^c   Bonnet, Jean Louis ^d   Carlsson, Marcus ^b   Clemmensen, Peter ^e   Cuvier, Valerie ^f   Danchin, Nicolas ^g   Dubois Randé, Jean Luc ^h   Engblom, Henrik ^b   Erlinge, David ^b   Firat, Huseyin ⁱ   Halvorsen, Sigrun ^a   SteenHansen, Henrik ^j   Hauke, Wilfried ^f   Heiberg, Einar ^b   Koul, Sasha ^b   Larsen, Alf Inge ^k   Le Corvoisier, Philippe ^h   Nordrehaug, Jan Erik ^l   Paganelli, Franck ^m   Pruss, Rebecca M ^f   Rousseau, Helene ⁿ   Schaller, Sophie ^f   Sonou, Giles ^o   Tuseth, Vegard ^l   Veys, Julien ^f   Vicaut, Eric ⁿ   Jensen, Svend Eggert ^p   more..

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^d TIMONE HOSPITAL   (France)

^e Rigshospitalet   (Denmark)

^f Trophos SA   (France)

^g HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^h HENRI MONDOR HOSPITAL   (France)

ⁱ Firalis SAS   (France)

^j ODENSE UNIVERSITY HOSPITAL   (Denmark)

^k STAVANGER UNIVERSITY HOSPITAL   (Norway)

^l UNIVERSITY OF BERGEN   (Norway)

^m HÔPITAL NORD   (France)

ⁿ HÔPITAL LARIBOISIÈRE   (France)

^o Mobile Health   (France)

^p AALBORG UNIVERSITY HOSPITAL   (Denmark)

more..

Author keywords

Cardiac reperfusion injury; CMR; Infarct size; Mitochondria; Primary PCI; STEMI

Indexed keywords

CARDIAC AGENT; CREATINE KINASE; PLACEBO; TRO 40303; TROPONIN I; UNCLASSIFIED DRUG; 3,5-SECO-4-NORCHOLESTAN-5-ONE OXIME-3-OL; CARDIOTONIC AGENT; CARRIER PROTEIN; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; OXIME; SECOSTEROID;

ADULT; AGED; ARTICLE; BALLOON DILATATION; BOLUS INJECTION; CARDIOGENIC SHOCK; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TIME TO TREATMENT; ANTAGONISTS AND INHIBITORS; AREA UNDER THE CURVE; CLINICAL TRIAL; CORONARY OCCLUSION; DOUBLE BLIND PROCEDURE; MAGNETIC RESONANCE ANGIOGRAPHY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROCEDURES; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON; AREA UNDER CURVE; CARDIOTONIC AGENTS; COMBINED MODALITY THERAPY; CORONARY OCCLUSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; OXIMES; PROSPECTIVE STUDIES; SECOSTEROIDS; TREATMENT OUTCOME;

EID: 84924094035     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu331     Document Type: Article

References (25)

1. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007;357: 1121-1135
2. Santoro GM, Carrabba N, Migliorini A, Parodi G, Valenti R. Acute heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention. Eur J Heart Fail 2008;10:780-785
3. Atar D, Petzelbauer P, Schwitter J, Huber K, Rensing B, Kasprzak JD, Butter C, Grip L, Hansen PR, Suselbeck T, Clemmensen PM, Marin-Galiano M, Geudelin B, Buser PT. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial. J Am Coll Cardiol 2009;53:720-729
4. Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, Elbelghiti R, Cung TT, Bonnefoy E, Angoulvant D, Macia C, Raczka F, Sportouch C, Gahide G, Finet G, Andre-Fouet X, Revel D, Kirkorian G, Monassier JP, Derumeaux G, Ovize M. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 2008;359:473-481
5. Lonborg J, Kelbaek H, Vejlstrup N, Botker HE, Kim WY, Holmvang L, Jørgensen E, Helqvist S, Saunamäki K, Terkelsen CJ, Schoos MM, Kober L, Clemmensen P, Treiman M, Engstrøm T. Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia. Circ Cardiovasc Interv 2012;5:288-295
6. Gotberg M, Olivecrona GK, Koul S, Carlsson M, Engblom H, Ugander M, van Der Pals J, Algotsson L, Arheden H, Erlinge D. A pilot study of rapid cooling by cold saline and endovascular cooling before reperfusion in patients with ST-elevation myocardial infarction. Circ Cardiovasc Interv 2010;3:400-407
7. Erlinge D, Gotberg M, Lang I, Holzer M, Noc M, Clemmensen P, Jensen U, Metzler B, James S, Botker HE, Omerovic E, Engblom H, Carlsson M, Arheden H, Ostlund O, Wallentin L, Harnek J, Olivecrona GK. Rapid endovascular catheter core cooling combined with cold saline as an adjunct to percutaneous coronary intervention for the treatment of acute myocardial infarction (The CHILL-MI trial). J Am Coll Cardiol 2014;63:1857-1865
8. Freixa X, Bellera N, Ortiz-Perez JT, Jimenez M, Pare C, Bosch X, De Caralt TM, Betriu A, Masotti M. Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention. Eur Heart J 2012;33: 103-112
9. Limalanathan S, Andersen GO, Klow NE, Abdelnoor M, Hoffmann P, Eritsland J. Effect of ischemic postconditioning on infarct size in patients with ST-elevation myocardial infarction treated by primary PCI results of the POSTEMI (POstconditioning in ST-Elevation Myocardial Infarction) randomized trial. J Am Heart Assoc 2014;3: e000679
10. Tarantini G, Favaretto E, Marra MP, Frigo AC, Napodano M, Cacciavillani L, Giovagnoni A, Renda P, De Biasio V, Plebani M, Mion M, Zaninotto M, Isabella G, Bilato C, Iliceto S. Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial. Int J Cardiol 2012;162:33-38
11. Heusch G. Reduction of infarct size by ischaemic post-conditioning in humans: fact or fiction?. Eur Heart J 2012;33:13-15
12. Heusch G. Cardioprotection: chances and challenges of its translation to the clinic. Lancet 2013;381:166-175
13. Sloth AD, Schmidt MR, Munk K, Kharbanda RK, Redington AN, Schmidt M, Pedersen L, Sorensen HT, Botker HE, CONDI Investigators. Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention. Eur Heart J 2014;35:168-175
14. Botker HE, Kharbanda R, Schmidt MR, Bottcher M, Kaltoft AK, Terkelsen CJ, Munk K, Andersen NH, Hansen TM, Trautner S, Lassen JF, Christiansen EH, Krusell LR, Kristensen SD, Thuesen L, Nielsen SS, Rehling M, Sørensen HT, Redington AN, Nielsen TT. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 2010;375:727-734
15. Lavi S, D'Alfonso S, Diamantouros P, Camuglia A, Garg P, Teefy P, Jablonsky G, Sridhar K, Lavi R. Remote ischemic postconditioning during percutaneous coronary interventions: remote ischemic postconditioning-percutaneous coronary intervention randomized trial. Circ Cardiovasc Interv 2014;7:225-232
16. Baines CP. The mitochondrial permeability transition pore and ischemia-reperfusion injury. Basic Res Cardiol 2009;104:181-188
17. Heusch G, Boengler K, Schulz R. Inhibition of mitochondrial permeability transition pore opening: the Holy Grail of cardioprotection. Basic Res Cardiol 2010;105: 151-154
18. Javadov S, Karmazyn M, Escobales N. Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases. J Pharmacol Exp Ther 2009;330:670-678
19. Schaller S, Paradis S, Ngoh GA, Assaly R, Buisson B, Drouot C, Ostuni MA, Lacapere JJ, Bassissi F, Bordet T, Berdeaux A, Jones SP, Morin D, Pruss RM. TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition. J Pharmacol Exp Ther 2010;333:696-706
20. Le Lamer S, Paradis S, Rahmouni H, Chaimbault C, Michaud M, Culcasi M, Afxantidis J, Latreille M, Berna P, Berdeaux A, Pietri S, Morin D, Donazzolo Y, Abitbol JL, Pruss RM, Schaller S. Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase I trial. J Translat Med 2014;12:38
21. MITOCARE study group. Rationale and design of the 'MITOCARE' Study: a phase II, multicenter, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of TRO40303 for the reduction of reperfusion injury in patients undergoing percutaneous coronary intervention for acute myocardial infarction. Cardiology 2012;123:201-207
22. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, Judd RM. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001;218:215-223
23. Sorensson P, Heiberg E, Saleh N, Bouvier F, Caidahl K, Tornvall P, Ryden L, Pernow J, ArhedenH. Assessment of myocardium at risk with contrast enhanced steady-state free precession cine cardiovascular magnetic resonance compared to single-photon emission computed tomography. J Cardiovasc Magn Reson 2010;12:25
24. Ubachs JF, Sorensson P, Engblom H, Carlsson M, Jovinge S, Pernow J, Arheden H. Myocardium at risk by magnetic resonance imaging: head-to-head comparison of T2-weighted imaging and contrast-enhanced steady-state free precession. Eur Heart J Cardiovasc Imaging 2012;13:1008-1015
25. Heiberg E, Ugander M, Engblom H, Gotberg M, Olivecrona GK, Erlinge D, Arheden H. Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom, and human study. Radiology 2008;246:581-588